Fed. Circ. Won't Revive Teva Challenge To Drug Patent
The Federal Circuit has refused to revive Teva Pharmaceuticals' bid at the Patent Trial and Appeal Board to sink a patent covering Corcept Therapeutics Inc.'s flagship Cushing's syndrome medication Korlym....To view the full article, register now.
Already a subscriber? Click here to view full article